COMMUNIQUÉS West-GlobeNewswire

Kyowa Kirin and Ultragenyx Announce Crysvita® (burosumab) Receives Conditional Marketing Authorization in Europe for the Treatment of X–Linked Hypophosphatemia in Children
23/02/2018
Crysvita is the First Treatment for XLH that Targets the Underlying Cause of the Disease Crysvita Acknowledged by European Medicines Agency as an Outstanding Contribution to Public Health TOKYO and LONDON and NOVATO, [...]
Strongbridge Biopharma plc Announces Annual General Meeting of Shareholders
23/02/2018
DUBLIN, Ireland and TREVOSE, Pa., Feb. 23, 2018 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc, (Nasdaq: SBBP ), a global commercial-stage biopharmaceutical company focused on the development and commercialization of [...]
L-DOS47 US Phase I Study Presentation at the IASLC 18th Annual Target Therapies of Lung Cancer Meeting
23/02/2018
RICHMOND HILL, Ontario, Feb. 23, 2018 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: HBP ) (FRANKFURT: HBP ) (“Helix” or the “Company”), a clinical stage immuno-oncology company developing innovative drug candidates [...]
Insmed Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Business Update
23/02/2018
On track to file NDA before the end of March and anticipate a priority review Extended amikacin liposome inhalation suspension ( ALIS) intellectual property protection to 2035 with issuance of ninth U.S. patent [...]
Spark Therapeutics to Participate in Multiple Conferences in March
23/02/2018
PHILADELPHIA, Feb. 23, 2018 (GLOBE NEWSWIRE) -- Spark Therapeutics (NASDAQ: ONCE ), a fully integrated gene therapy company dedicated to challenging the inevitability of genetic disease, today announced that Arlene V. [...]
Update: Montebello to distribute Biohit products in Norway
23/02/2018
Biohit Oyj Press release, February 23rd, 2018 at 10:00 a.m. local time (EET) Biohit Oyj and Montebello Diagnostics AS have signed an agreement for the distribution of Biohit diagnostic products in Norway. The contract [...]
Summit Therapeutics to Participate in 2018 BTIG Healthcare Conference
23/02/2018
Summit Therapeutics plc ("Summit", or the "Company") SUMMIT THERAPEUTICS TO PARTICIPATE IN 2018 BTIG HEALTHCARE CONFERENCE Oxford, UK, 23 February 2018 - Summit Therapeutics plc (NASDAQ: SMMT, AIM: SUMM), the drug [...]
Surgery Partners Names Angela Justice Chief Human Resource Officer
23/02/2018
Newly created position highlights the importance of talent development to the Company’s long-term growth strategy Executive with extensive experience in building teams, effecting cultural change and driving business [...]
Leap Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results and Announces Date of its Annual Meeting of Stockholders
23/02/2018
CAMBRIDGE, Mass., Feb. 23, 2018 (GLOBE NEWSWIRE) -- Leap Therapeutics, Inc. (Nasdaq: LPTX ), a biotechnology company developing targeted and immuno-oncology therapeutics, today reported financial results for the fourth [...]
Apellis Pharmaceuticals to Participate in Upcoming Investor Conferences
23/02/2018
CRESTWOOD, Ky. and CAMBRIDGE, Mass., Feb. 23, 2018 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS ), a clinical-stage biopharmaceutical company developing a platform of novel therapeutic compounds for [...]
Summit Therapeutics to Participate in 2018 BTIG Healthcare Conference
23/02/2018
OXFORD, United Kingdom, Feb. 23, 2018 (GLOBE NEWSWIRE) -- Summit Therapeutics plc (NASDAQ: SMMT ) (AIM:SUMM), the drug discovery and development company advancing therapies for rare diseases and infectious diseases, [...]
Bellicum Announces Update on Clinical Hold of U.S. BPX-501 Studies
23/02/2018
HOUSTON, Feb. 23, 2018 (GLOBE NEWSWIRE) -- Bellicum Pharmaceuticals, Inc. (NASDAQ: BLCM ), a leader in developing novel, controllable cellular immunotherapies for cancers and orphan inherited blood disorders, today [...]
Avivagen Announces Two Year Distribution Agreement with PACC Pets and Attendance at Global Pet Expo
23/02/2018
OTTAWA, Feb. 23, 2018 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (OTC Pink:CHEXF) (“ Avivagen ” or the “ Company ”), a life sciences innovation company with a series of patent protected products that support and [...]
Insider's tradings
23/02/2018
Nasdaq Copenhagen 23 February 2018 Report on transactions of executives and related parties in Coloplast shares and related securities According to the Market Abuse Regulation art. 19 Coloplast is obliged to report on [...]
Digirad Corporation Reports Financial Results for the Fourth Quarter and Twelve Months Ended December 31, 2017
23/02/2018
Performs within guidance for Revenue and EBITDA for 2017 MDSS service contracts divestiture completed Company continues to pay regular quarterly dividend of $0.055 cents per share SUWANEE, Ga., Feb. 23, 2018 (GLOBE [...]
HMS Holdings Corp. Reports Fourth Quarter and Full Year 2017 Results
23/02/2018
4Q GAAP EPS of $0.30 Per Diluted Share / Full Year GAAP EPS of $0.47 Per Diluted Share 4Q Adjusted EPS of $0.49 Per Diluted Share / Full Year Adjusted EPS of $1.11 Per Diluted Share Federal Tax Law Changes Resulted in [...]
Veritas Pharma Completes Share Purchase Agreement of Sechelt Organic Marijuana Corp.
23/02/2018
VANCOUVER, British Columbia, Feb. 23, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt: 2VP ) , (“Veritas” or the “Company”) is pleased to announce that it has completed the Share Purchase [...]
Sanofi: Hart-Scott-Rodino waiting period expires for Sanofi's acquisition of Bioverativ
23/02/2018
Hart-Scott-Rodino waiting period expires for Sanofi's acquisition of Bioverativ Paris - February 23, 2018 - Sanofi announced today that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, [...]
Sanofi : Sanofi annonce l'expiration de la période d'attente prévue par la loi Hart-Scott-Rodino pour l'acquisition de Bioverativ
23/02/2018
Sanofi annonce l'expiration de la période d'attente prévue par la loi Hart-Scott-Rodino pour l'acquisition de Bioverativ Paris - Le 23 février 2018 - Sanofi annonce aujourd'hui la fin de la période d'attente prévue par [...]

Pages